https://www.indianpharmapost.com/merck-to-expand-reagent-production-capacity-in-china-143372023-06-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/enpicom-secures-extended-financing-from-current-investors-143382023-06-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/lupin-achieves-milestone-for-its-phase-1-clinical-stage-malt1-inhibitor-program-143392023-06-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/shilpa-medicare-launches-lenvatinib-capsules-in-india-under-the-brand-name-lenshil-143402023-06-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/rystiggo-needs-marketing-strategy-to-fully-compete-in-myasthenia-gravis-space-says-globaldata-143412023-06-30T00:00:00+05:30always0.9